发明名称 |
Phosphorus-32 labeling of antibodies for cancer therapy |
摘要 |
Recombinant fusion proteins containing at least one domain which confers targeting properties on the fusion protein, together with at least one peptide sequence that is a substrate for a protein kinase, can be labeled with <32>P or <33>P by treatment with a protein kinase and a <32>P- or <33>P-labeled phosphate donor. The labeled targeting proteins bind specifically to diseased cells or tissue, which are killed by the radiation from the <32>P or <33>P. |
申请公布号 |
AU3548895(A) |
申请公布日期 |
1996.03.29 |
申请号 |
AU19950035488 |
申请日期 |
1995.09.18 |
申请人 |
IMMUNOMEDICS, INC. |
发明人 |
SHUI-ON LEUNG;HANS J. HANSEN;GARY L. GRIFFITHS |
分类号 |
C12N15/09;A61K38/00;A61K51/00;C07K1/13;C07K7/06;C07K7/08;C07K14/54;C07K16/30;C07K19/00;C12P21/02;C12R1/19 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|